Pernix Therapeutics Holdings (PTX) gains on FDA nod

Pernix Therapeutics Holdings Inc

shares gained 7.3% to $6.93 after the company reported the FDA approval for TREXIMET for use in pediatric patients. Share volume was 662,000, compared to an all-day average of 249,000